The role of Lp(a) and oxPLs in atherosclerosis

The role of Lp(a) and oxPLs in atherosclerosis

We are delighted to welcome Prof Sotirios (Sam) TSIMIKAS to the HEART UK conference on 7 July to present current and future therapeutic agents and interventions targeting Lp(a) and oxPLs.

Dr. Tsimikas is Professor of Medicine and the Director of Vascular Medicine at the University of California San Diego School of Medicine. His education and training included obtaining his MD degree from the University of Massachusetts Medical School, Internal Medicine training at the University of Massachusetts Medical Center, and separate fellowships in Cardiovascular Medicine, Atherosclerosis and Molecular Medicine and Interventional Cardiology at the University of California San Diego (UCSD( Medical Center. Dr. Tsimikas is the Founding Director of the Vascular Medicine Program withing the Cardiovascular Medicine Division, which encompasses treating patients in the continuum of high-risk primary prevention to endovascular intervention.